Transportation to Cancer Treatments is An Issue for Many Patients

Video

As transportation to treatments is one of the many important aspects patients with cancer must consider after receiving a diagnosis, there is room for improvement in terms of accessibility and affordability, says an expert from the Patient Access Network Foundation.

Transportation is a frequently overlooked, yet nonetheless important aspect of a patient’s cancer journey. Many patients have to work out the logistics on how they’re getting to and from treatment, which can become a large concern if they can’t afford or access transportation, says Ayesha Azam, Vice President of the Patient Access Network (PAN) Foundation.

In an interview with CURE®, Azam discussed the PAN Foundation’s goal of increasing accessibility to affordable transportation for patients.

“Part of our efforts are to draw attention to so many of the non-emergency medical transportation carriers that are across the U.S. that can provide people who maybe do have accessibility concerns, or maybe who don't have a car available to them, access to a vehicle that can take them safely to where they need to go,” Azam said.

Transcription:

It's such a pivotal role, and part of it has to do with the security and reliability of making sure that you can get your treatment and not have to worry about who's taking you to treatment.

We did a survey almost two years ago now, about all patients who are receiving copay assistance, many of which have cancelled. What we found from speaking to them is that most folks are relying on other people to be able to get to their doctor's office and pharmacies. And not only that, but the way that they’re traveling to the appointments may vary at each appointment. So, one time they might be relying on a friend or one time might be relying on a family member. And so, what we really found is that not only is there as big of a concern on the affordability end, but there was an equal level of concern on the accessibility end.

And so, part of our efforts are to draw to attention, so many of the non-emergency medical transportation carriers that are across the US that can provide people who maybe do have accessibility concerns, or maybe who don't have a car available to them, access to a vehicle that can take them safely to where they need to go.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE
Related Content